Sindhu R Johnson

Administrative Assistant: 

Toronto Western Hospital: Rosa Tavares 416-603-6417

Mount Sinai Hospital: Dalage Morris 416-586-4800 x8247

Research Synopsis

Dr. Sindhu Johnson is a Rheumatologist, Clinical Epidemiologist and Clinician-Scientist at the University Health Network and Sinai Health Systems. She is a Professor in the Department of Medicine at the University of Toronto; and Program Director of the Clinical Epidemiology & Health Care Research Program at IHPME. Her program of research develops methodologic platforms that combine data-driven and expert-based methods with advanced analytic techniques to define disease states, develop outcome measures, develop guidelines, and study treatment effects. This methodologic work was developed using the model of scleroderma and has now expanded across rheumatic diseases.

She has published >250 articles in peer reviewed journals, secured $8 million dollars in salary support and operating grant funding, published 5 book chapters, and invited to 4 Editorial Boards. She has been an investigator for trials that led to the first two US Food and Drug Administration approved medications for scleroderma associated interstitial lung disease (nintedinib (NEJM 2019), tocilizumab (Arthritis Rheum 2020)). She has supervised 20 international clinical research fellows and graduate students, most of who have established Scleroderma Programs in their home countries or now have academic appointments.